Stock Based Compensation (Tables)

9 Months Ended

Sep. 30, 2022

Stock Based Compensation

Summary of incentive plan activity

				Weighted		Weighted Average
	Shares	Stock		Average		Remaining	Aggregate
	Available	Options	RSUs	Stock Option		Contractual Life	Intrinsic
(in thousands, except share and per share data)	for Grant	Outstanding	Outstanding	Exercise Price		(Years)	Value*
Outstanding at December 31, 2021	631,270	2,503,075	487,456	$	9.44	8.35	$	3
Additional shares authorized	2,889,495	—	—		—			—
Options granted	(3,333)	3,333	—		0.31			—
Options exercised	—	—	—		—			—
Options canceled	70,903	(70,903)	—		3.92			—
RSUs granted	(2,893,720)	—	2,893,720		—			—
Outstanding at September 30, 2022	694,615	2,435,505	3,381,176	$	9.59	7.59	$	—
Exercisable at September 30, 2022		1,925,768		$	10.76	7.36	$	—
Vested and expected to vest at September 30, 2022		2,379,802		$	9.69	7.57	$	—

*Fair market value of JAGX common stock on September 30, 2022 was $0.16 per share.

Summary of stock-based compensation expense

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(in thousands)	2022		2021		2022		2021
	(unaudited)				(unaudited)
Research and development expense	$	354	$	404	$	1,067	$	935
Sales and marketing expense		32		88		234		208
General and administrative expense		455		673		1,620		1,689
Total	$	841	$	1,165	$	2,921	$	2,832

Employee stock options

Stock Based Compensation

Schedule of estimated grant-date fair value of stock options calculated using the Black-Scholes option-pricing model

	Nine Months Ended
	September 30,
	2022	2021
	(unaudited)
Volatility	164.0%	163.8 - 164.0 %
Expected term (years)	5.0	5.0
Risk-free interest rate	3.2%	0.5 - 1.0 %
Expected dividend yield	—	—